Freezing of Aqueous Solutions and Chemical Stability of Amorphous Pharmaceuticals: Water Clusters Hypothesis.

amorphism chemical stability deamidation freeze-drying lyophilization protein formulation(s) solid-state stability structure water sorption

Journal

Journal of pharmaceutical sciences
ISSN: 1520-6017
Titre abrégé: J Pharm Sci
Pays: United States
ID NLM: 2985195R

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 08 05 2018
revised: 13 07 2018
accepted: 17 07 2018
pubmed: 29 7 2018
medline: 15 2 2020
entrez: 29 7 2018
Statut: ppublish

Résumé

Molecular mobility has been traditionally invoked to explain physical and chemical stability of diverse pharmaceutical systems. Although the molecular mobility concept has been credited with creating a scientific basis for stabilization of amorphous pharmaceuticals and biopharmaceuticals, it has become increasingly clear that this approach represents only a partial description of the underlying fundamental principles. An additional mechanism is proposed herein to address 2 key questions: (1) the existence of unfrozen water (i.e., partial or complete freezing inhibition) in aqueous solutions at subzero temperatures and (2) the role of water in the chemical stability of amorphous pharmaceuticals. These apparently distant phenomena are linked via the concept of water clusters. In particular, freezing inhibition is associated with the confinement of water clusters in a solidified matrix of an amorphous solute, with nanoscaled water clusters being observed in aqueous glasses using wide-angle neutron scattering. The chemical instability is suggested to be directly related to the catalysis of proton transfer by water clusters, considering that proton transfer is the key elementary reaction in many chemical processes, including such common reactions as hydrolysis and deamidation.

Identifiants

pubmed: 30055227
pii: S0022-3549(18)30453-2
doi: 10.1016/j.xphs.2018.07.018
pii:
doi:

Substances chimiques

Solutions 0
Water 059QF0KO0R

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

36-49

Informations de copyright

Copyright © 2019 Allergan, PLC. Published by Elsevier Inc. All rights reserved.

Auteurs

Evgenyi Shalaev (E)

Pharmaceutical Development, Allergan plc., Irvine, California 92612. Electronic address: Shalaev_Evgenyi@Allergan.com.

Alan Soper (A)

ISIS Facility, UKRI-STFC Rutherford Appleton Laboratory, Harwell Campus, Didcot, Oxon OX11 OQX, UK.

J Axel Zeitler (JA)

Department of Chemical Engineering and Biotechnology, University of Cambridge, Philippa Fawcett Drive, Cambridge CB3 0AS, UK.

Satoshi Ohtake (S)

Pfizer BioTherapeutics Pharmaceutical Sciences, Chesterfield, Missouri 63198.

Christopher J Roberts (CJ)

Department of Chemical Engineering, University of Delaware, Newark, Delaware 19716.

Michael J Pikal (MJ)

Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, Connecticut 06269.

Ke Wu (K)

Pharmaceutical Development, Allergan plc., Irvine, California 92612.

Elena Boldyreva (E)

Novosibirsk State University, Pirogova Street 2, Novosibirsk 630090, Russian Federation; Boreskov Institute of Catalysis SB RAS, Novosibirsk 630090, Russian Federation.

Articles similaires

Animals Dietary Fiber Dextran Sulfate Mice Disease Models, Animal
Silicon Dioxide Water Hot Temperature Compressive Strength X-Ray Diffraction
1.00
Oryza Agricultural Irrigation Potassium Sodium Soil

Classifications MeSH